Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between the Effects of Low-Dose Semaglutide With Metformin vs. Metformin Alone Over Metabolic Profile in Obese Polycystic Ovary Syndrome: A Phase II Randomized Controlled Trial

NCT06896981 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT06896981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06896981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between the Effects of Low-Dose Semaglutide With Metformin vs. Metformin Alone Over Metabolic Profile in Obese Polycystic Ovary Syndrome: A Phase II Randomized Controlled Trial
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 2/3
Overall status
Completed
Start date
January 1, 2025
Completion date
February 28, 2026
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, polycystic ovary syndrome (pcos) women